ω3‐polyunsaturated fatty acids suppress lipoprotein‐associated phospholipase A2 expression in macrophages and animal models

zhuang li,wenzhi ren,xiaolei han,xingxing liu,gangqi wang,mingjun zhang,daxin pang,hongsheng ouyang,xiaochun tang
DOI: https://doi.org/10.1002/mnfr.201500022
IF: 6.5749
2015-01-01
Molecular Nutrition & Food Research
Abstract:Scope: omega 3-polyunsaturated fatty acids (omega 3-PUFAs) have beneficial effects on cardiovascular function, and lipoprotein-associated phospholipase A2 (Lp-PLA(2)) is associated with the risk of cardiovascular disease. Here, we investigated the effects of omega 3-PUFAs on Lp-PLA(2) expression in vitro and in vivo and explored the mechanisms involved. Methods and results: Human monocyticcells (THP-1) were induced into macrophages in an in vitro model. omega 3-PUFAs suppressed Lp-PLA(2) expression; the suppression induced by docosahexaenoic acid (DHA) was related to reduced inflammation. Tumor necrosis factor-alpha (TNF-alpha) was employed to stimulate the phosphorylation of p38 mitogen-activated protein kinase (MAPK), nuclear factor-kappa B (NF-kappa B) p65 and Lp-PLA(2) expression in macrophages. The stimulation was inhibited by DHA and the anti-inflammatory drug sodium salicylate. Moreover, the stimulation of Lp-PLA(2) expression by TNF-alpha could be suppressed by NF-kappa B and MAPK pathway inhibitors. Then, chronic inflammation was induced in an in vivo mouse model, resulting in an increase in Lp-PLA(2) expression in peripheral blood mononuclear cells (PBMCs) and arteries. This increase was suppressed by omega 3-PUFAs. Inhibition of Lp-PLA(2) transcription in PBMCs was also observed in omega 3-PUFA-enriched swine. Conclusion: Our results demonstrate that the protective effects of omega 3-PUFAs against cardiovascular events may be related to the suppression of Lp-PLA(2) levels.
What problem does this paper attempt to address?